# Platform Technology Designation Program for Drug Development - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/platform-technology-designation-program-for-drug-development/c0869fde-efe2-459a-bb5d-9ae107865376

> FDA guidance document: Platform Technology Designation Program for Drug Development. Issue date: May 28, 2024. Get complete insights and analysis.

---

## Details

- Title: Platform Technology Designation Program for Drug Development
- Communication Type: Guidance Document
- Product Type: biologics
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2024-05-28
- Comment Close Date: 2024-07-29
- Last Changed: 2024-05-29
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2024-D-1829">FDA-2024-D-1829</a>

## Related Documents

- [Drug Master Files Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/drug-master-files-guidance-for-industry/7dfd5140-3156-43f2-bdb9-d23ad597311c)
- [Pharmacogenomic Data Submissions](https://www.globalkeysolutions.net/guidances/guidance-document/pharmacogenomic-data-submissions/9a29ff18-0847-4eaa-b84e-2e4b7bd5d29e)
- [Crohn’s Disease:  Developing Drugs for Treatment](https://www.globalkeysolutions.net/guidances/guidance-document/crohns-disease-developing-drugs-for-treatment/10ab5c94-72ed-489d-b2cc-24cf6914fed5)